About Fermenta Biotech Ltd
Fermenta Biotech is engaged in the business of manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations and environmental solution products and renting and selling of properties. The Company caters to both domestic and international markets.
Founded
1951
CEO
Pradeep Manjunath Chandan
Employees
891
HQ
Thane (West), Maharashtra
Finished Products
1Revenue from Contrqacts
₹1,038.75Cr2Sale of Investment property
₹110.09Cr3Service Income
₹22.67Cr4Rental Income
₹9.03Cr5Export incentive
₹3.72Cr6Other operating income
₹2.01Cr7Amortised deffered rent
₹0.88Cr1–7 of 8
Raw Materials
1Raw Material Consumed
₹379.34Cr2Purchase of Finished Goods
₹36.52CrAbout Fermenta Biotech Ltd
Fermenta Biotech is engaged in the business of manufacturing and marketing of chemicals, bulk drugs, enzymes, pharmaceutical formulations and environmental solution products and renting and selling of properties. The Company caters to both domestic and international markets.
Founded:1951
CEO:Pradeep Manjunath Chandan
Employees:891
HQ:Thane (West), Maharashtra
Finished Products
1Revenue from Contrqacts
₹1,038.75Cr2Sale of Investment property
₹110.09Cr3Service Income
₹22.67Cr4Rental Income
₹9.03Cr5Export incentive
₹3.72Cr6Other operating income
₹2.01Cr7Amortised deffered rent
₹0.88Cr1–7 of 8
Raw Materials
1Raw Material Consumed
₹379.34Cr2Purchase of Finished Goods
₹36.52CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹580
52W Low
₹249
Volume159.54K
Avg VolumeN/A
Beta0.85
Dividend Yield0.70%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
26.44x
Valuation
P/B Ratio
3.78x
Valuation
EPS
₹19.77
Valuation
Dividend Yield
0.70%
Valuation
ROE
17.67%
Profitability
ROCE
20.02%
Profitability
Revenue by Segment
Contribution & growth by business line
Bulk Drug/Chemicals
+28.5%98.2%
₹514.72 Cr
Property
-82.5%1.8%
₹9.51 Cr
Geographical Revenue Split
Domestic vs international exposure
Domestic
39.3%
International
60.7%
India39.3%
Europe29.5%
Others countries17.8%
USA13.3%
Strategic Relations
Collaborations, joint ventures & subsidiaries
S
Solvay Duphar B V
Netherland
19.41% stakeB
British Colloids
United Kingdom
19.41% stakeForensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.28x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
16.1%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.